The rising prevalence in GLP-1 agonists for diabetes has generated a question about application forms : skin-applied devices versus tablets . Traditionally , GLP-1 drugs were solely available in tablet https://emilietwsp327722.bloguetechno.com/glp-1-transdermal-delivery-systems-vs-tablets-is-best-for-the-patient-77525136